Spot Trading’s Acadia Healthcare ACHC Stock Holding History

Spot Trading’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-2,834	Closed	-$157K	–	3003
2016 Q2	$157K	Buy	+2,834	New	+$166K	﹤0.01%	2352

Other funds holding ACHC

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Spot Trading's ACHC Position: Q3 2016 in Review

Spot Trading sold out of Acadia Healthcare (ACHC) in Q3 2016, closing a stake of 2,834 shares — an estimated $157K sold.

Spot Trading first reported a position in ACHC in Q2 2016 and held it in 1 quarter. The position peaked at $157K in Q2 2016. 255 funds tracked by Wall St. Rank hold ACHC as of Q3 2016.

Spot Trading reported no remaining Acadia Healthcare position as of Q3 2016 after selling out during the quarter.
Spot Trading sold 2,834 Acadia Healthcare shares in Q3 2016, an estimated $157K.
Spot Trading first reported a position in Acadia Healthcare in Q2 2016 and held it in 1 quarter.
Spot Trading's Acadia Healthcare position peaked at $157K in Q2 2016.
255 funds tracked by Wall St. Rank held Acadia Healthcare as of Q3 2016.

Based on Spot Trading's 13F filing for Q3 2016, filed 31 Oct 2016.